ENZON PHARMACEUTICALS, INC.
ENZON PHARMACEUTICALS, INC. (ENZN): ~17 mo cash runway. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
16.6 months
0% dilution
N/A
N/A
N/A
N/A
A transparent, data-derived signal for ENZON PHARMACEUTICALS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$37.0M
Cash
$28.6M
Quarterly Burn
$16.3M
Runway
16.6 mo
Revenue
$86.5M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Frequently asked questions
What is ENZON PHARMACEUTICALS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ENZON PHARMACEUTICALS, INC. has approximately 16.6 months of cash runway.
What is ENZON PHARMACEUTICALS, INC.'s market capitalization?
ENZON PHARMACEUTICALS, INC.'s market capitalization is approximately $37.0M.
Who is the CEO of ENZON PHARMACEUTICALS, INC.?
Mr. Richard L. Feinstein CPA is the chief executive officer of ENZON PHARMACEUTICALS, INC. (ENZN).
Get the full picture on ENZON PHARMACEUTICALS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.